处方药价格:一个AAN立场声明
Jonathan D Santoro1, Jason J Sico1, James F Burke1
1From the Keck School of Medicine of USC and Children's Hospital Los Angeles (J.D.S.), CA; Yale School of Medicine (J.J.S.), Orange, CT; Ohio State Wexner Medical Center (J.F.B.), Columbus; Ochsner Health (K.S.), New Orleans, LA; American Academy of Neurology (M.T.), Minneapolis, MN; Texas Neurology (D.A.E.), Dallas; Massachusetts General Hospital and Harvard Medical School (J.T.J.), Boston.
Neurology
|February 9, 2024
概括
美国神经病学会 (AAN) 针对神经病症的处方药高成本问题. 他们倡导解决方案,确保患者获得负担得起,高价值的治疗.
科学领域:
- 神经学 神经学
- 卫生经济学 卫生经济学
- 卫生政策 卫生政策
背景情况:
- 高昂的处方药费用对神经疾病治疗提出了挑战.
- 神经科医生的目标是以尽可能低的成本提供高价值的护理.
- 有几个因素导致药物价格上,包括不合理的增加和罕见病药物的高成本.
研究的目的:
- 确定美国神经病学会 (AAN) 关于处方药费用控制策略的立场.
- 告知决策者关于AAN在解决药物定价问题上的立场.
- 确保复杂,慢性神经疾病患者能够获得有效的处方药.
主要方法:
- 美国药物协会根据对当前药品定价挑战的分析,制定了一份立场声明.
- 该声明概述了AAN对高成本神经疗法的价值主张的担忧.
- 该AAN考虑了潜在的解决方案及其对患者和医疗保健系统的影响.
主要成果:
- 确定了三个主要的成本挑战:不合理的价格上,罕见病药物的高成本和非创新疗法的高成本.
- 表示关切的是,高成本并不总是相当于足够的患者或社会价值.
- 强调,如果不仔细管理,成本控制努力可能会对患者和处方医生的准入产生负面影响.
结论:
- 采取行动是必要的,以确保获得有效的处方药用于神经系统疾病.
- 建议的解决方案必须是负担得起的,简单的,透明的.
- 美国药物协会支持包括价格谈判,仿制药/生物类似药,新疗法开发,价格透明度和进口在内的战略.
相关概念视频
01:02Prescription, Nonprescription and Orphan Drugs
728
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
728
01:03Drug Control Governance: Regulatory Bodies and Their Impact
158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:17Drug Nomenclature
1.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.7K
01:15Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
01:24Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K